Adia Nutrition Joins PI Doctors Elite Community as Preferred Vendor Unlocking Access to a $50 Billion Personal Injury Care Market
Winter Park, Florida--(Newsfile Corp. - August 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine and personalized healthcare, announced that its laboratory division, Adia Labs, has been selected as a preferred vendor for the PI Doctors Elite Community. This national network includes over 4,000 personal injury physicians across various specialties, providing Adia Labs with access to a robust referral base serving injury patients throughou
Healthcare and Hospitals, Health
2025-08-28 9:00 AM EDT | Adia Nutrition Inc.
Cosmo Receives Positive CHMP Opinion for Winlevi(R) for Treatment of Acne in Adults and Adolescents, Following Successful Re-Examination
Dublin, Ireland--(Newsfile Corp. - August 27, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending European approval of Winlevi® (clascoterone 1% cream) for the treatment of facial acne vulgaris in both adults and adolescents aged 12 to <18 years. The
Healthcare and Hospitals, Health
2025-08-27 1:05 AM EDT | Cosmo Pharmaceuticals N.V.
Theralase(R) Releases 2Q2025 Financial Statements
Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses has released the Company's unaudited condensed consolidated interim 2Q2025 financial statements ("Financial Statements"). Theralase® will be host
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-08-26 4:30 PM EDT | Theralase Technologies Inc.
AI Turns Daily Home OCT Images into Actionable Disease Insights for Retina Specialists
Manassas, Virginia--(Newsfile Corp. - August 26, 2025) - A new study published in Ophthalmology Science validates that artificial intelligence (AI) can accurately track disease activity in patients with wet age-related macular degeneration (AMD) by analyzing up-to daily home OCT images.1 This approach adds a new dimension to patient management by allowing physicians to follow biomarker trajectories over time and assess response to treatment more effectively. The SCANLY
Healthcare and Hospitals, Health
2025-08-26 8:00 AM EDT | Notal Vision
Adia Med Surges Ahead of Growth Timeline With Venture Medical Partnership in $25B Wound Care Market
Winter Park, Florida--(Newsfile Corp. - August 26, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a bold leader in regenerative medicine and personalized healthcare, today announced a thrilling partnership between its clinical division, Adia Med, and Venture Medical. This electrifying collaboration launches Adia Med into the epicenter of insurance-ready wound repair, igniting a high-margin revenue stream within the colossal $25 billion U.S. wound care market and setting the stage for transformati
Healthcare and Hospitals, Health
2025-08-26 8:00 AM EDT | Adia Nutrition Inc.
Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board
White Bear Lake, Minnesota--(Newsfile Corp. - August 26, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced it has satisfied and extinguished the outstanding term loans from GAT Funding, LLC, which totaled $32 million in outstanding principal and accrued interest, in exchange for a payment of $100,000 in cash. GAT Funding is owned by Glen A. Taylor, wh
Biotechnology, Healthcare and Hospitals
2025-08-26 8:00 AM EDT | Envoy Medical, Inc.
NervGen Pharma Reports Second Quarter Financial Results and Provides Letter to Shareholders
Announced unprecedented Phase 1b/2a topline results in chronic spinal cord injury NVG-291 is the first pharmacologic candidate to demonstrate statistically significant improvement in corticospinal connectivity with clinically meaningful functional gains Ongoing comprehensive analysis of NVG-291's efficacy profile will support upcoming regulatory discussions, including seeking alignment with FDA on potential expedited approv
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-08-26 7:30 AM EDT | NervGen Pharma Corp.
FendX Advances Medical Catheter Coating Innovation: Provisional Patent Filed
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTD) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing their technology-based solutions to reduce the spread of harmful pathogens and support a cleaner, safer world, is pleased to announce the filing of a provisional patent application with the United States Patent and Trademark Office. The application, titled "Lubricate
Technology, Healthcare and Hospitals, Health
2025-08-26 6:00 AM EDT | FendX Technologies Inc.
NuGen Medical Devices Announces New Needle-Free Injection System Featuring Internal Cartridge Technology
Toronto, Ontario--(Newsfile Corp. - August 21, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to announce research and development of a next-generation needle-free injection system, in drug delivery technology. This innovation, protected under international patent WO2021206553 (granted in the EU and China; pending in Canada and the US), introduces a cartridge-based solut
Healthcare and Hospitals, Pharmaceuticals, Health
2025-08-21 5:15 PM EDT | NuGen Medical Devices Inc.
Adia Nutrition Launches Second National Television Campaign Showcasing U.S.-Based Regenerative Stem Cell Therapies
Winter Park, Florida--(Newsfile Corp. - August 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized healthcare, today announced the launch of its second nationwide television campaign. The commercial highlights Adia Med, the company's clinical division, and its advanced regenerative stem cell treatments now available at the flagship Winter Park, Florida clinic. These therapies are designed for a wide range of conditions including sp
Healthcare and Hospitals, Health
2025-08-21 10:00 AM EDT | Adia Nutrition Inc.
NervGen Pharma's NVG-291-R Demonstrates Significant Functional Recovery in Department of Defense-Sponsored Preclinical Models of Traumatic Hearing Loss and Peripheral Nerve Injury
Vancouver, British Columbia--(Newsfile Corp. - August 21, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biopha
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-08-21 7:30 AM EDT | NervGen Pharma Corp.
VitalHub Closes $74.75 Million Bought Deal Public Offering with Full Exercise of Over-Allotment Option
Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is pleased to announce that it has closed its previously announced bought deal offering pursuant to a press release dated August 15, 2025. A total of 5,885,828 common shares of VitalHub (the "Common Shares") were sold at a price of $12.70 per Common Share for total gross proceeds of approximately $74.75 million, which included the full exerc
Healthcare and Hospitals, Blockchain, Health
2025-08-20 10:01 AM EDT | VitalHub Corp.
Adia Med Expands Into Wound Care, Targeting High-Demand $25 Billion Market and Unlocking New Growth Avenues
Winter Park, Florida--(Newsfile Corp. - August 20, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company at the forefront of regenerative medicine and personalized health solutions, today announced that its clinical division, Adia Med, is officially expanding into the high-demand field of advanced wound care. This strategic move enables the company to serve a wider patient base, meet a critical and growing healthcare need, and open a new stream of revenue that supports long-ter
Healthcare and Hospitals, Health
2025-08-20 8:00 AM EDT | Adia Nutrition Inc.
Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology
White Bear Lake, Minnesota--(Newsfile Corp. - August 20, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the issuance of three new pa
Biotechnology, Healthcare and Hospitals
2025-08-20 8:00 AM EDT | Envoy Medical, Inc.
AI-Powered Pathogen Detection App: Provisional Patent Filed by FendX CEO
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), an innovative surface protection company developing their technology-based solutions to reduce the spread of harmful pathogens and support a cleaner, safer world, is pleased to announce that its CEO, Dr. Carolyn Myers, has filed a provisional patent application with the United States Patent and Trademar
Technology, Healthcare and Hospitals, Health
2025-08-20 6:30 AM EDT | FendX Technologies Inc.
Bachem Expands Corporate Executive Committee to Include Chief Operations Officer Role
Bubendorf, Switzerland--(Newsfile Corp. - August 20, 2025) - The Bachem Group (SIX: BANB) announced today that Hans Van Hees, currently Chief Operations Officer Europe, will take on the role of Chief Operations Officer (COO) and join the Corporate Executive Committee (CEC) as of September 1, 2025. In this role, he will report to the CEO of Bachem, Thomas Meier, and will lead Bachem’s worldwide manufacturing network. Thomas Meier, who, in addition to his role as CEO, had
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2025-08-20 1:08 AM EDT | Bachem Holding AG
Discovery Senior Living Appoints President of Arvum and SummerHouse Senior Living
Bonita Springs, Florida--(Newsfile Corp. - August 19, 2025) - Discovery Senior Living, one of the nation's most trusted and fastest-growing senior housing operators, is pleased to announce the appointment of Richard Totorico as President of Arvum and SummerHouse Senior Living, effective immediately. Richard's career with Discovery began nearly a decade ago when he joined The Trace as Executive Director in 2013, a community later acquired by Discovery in 2016. Since then, he has advanced
Healthcare and Hospitals, Real Estate, Housing
2025-08-19 4:54 PM EDT | Discovery Senior Living
NewOrg Publishes Free Resource on Navigating the Nonprofit Case Management Landscape
Washington, D.C.--(Newsfile Corp. - August 19, 2025) - NewOrg, the highest-rated provider for cloud-based case management software for nonprofits and human service organizations, has published a new guide: Modern Nonprofit Case Management: Trends, Tools, and Digital Transformation. The guide addresses the growing pressures facing nonprofits as they juggle complex client needs, multiple programs, and strict report
Computer Software, Healthcare and Hospitals, Housing, Aboriginal / Indigenous
2025-08-19 1:00 PM EDT | NewOrg Management System Inc
Discovery Senior Living to Participate at 2025 Fall NIC Conference, and Interface Seniors Housing Southeast, August 26-27
Bonita Springs, Florida--(Newsfile Corp. - August 18, 2025) - Discovery Senior Living ("Discovery" or the "Company") one of the nation's largest most trusted senior housing operators, is pleased to announce its Chief Executive Officer, Richard Hutchinson, along with senior executives and members of its leadership team, will attend the Fall National Investment Center (NIC) Conference in Austin, Texas, from September 8-11, 2025. The team will be available for one-on-one meetings w
Healthcare and Hospitals, Real Estate, Housing
2025-08-18 5:41 PM EDT | Discovery Senior Living
Discovery Senior Living Appoints President of Arvum and SummerHouse Senior Living
Bonita Spring, Florida--(Newsfile Corp. - August 18, 2025) - Discovery Senior Living ("Discovery" or the "Company") one of the largest and most trusted senior housing operators in the U.S., is pleased to announce the appointment of Richard Totorico as President of Arvum and SummerHouse Senior Living, effective immediately. Richard's career with Discovery began nearly a decade ago when he joined The Trace as Executive Director in 2013, a community later acquired by Discovery in 2
Healthcare and Hospitals, Real Estate, Housing
2025-08-18 10:08 AM EDT | Discovery Senior Living